“…However, it may not always be necessary or possible to identify a specific pathway or AOP for a chemical to carry out a risk assessment. In some cases, risk assessments can be completed using low tier approaches such as exposure-based waiving ( Yang et al , 2017 ), history of safe use ( Constable et al , 2007 ; Neely et al , 2011 ), read-across ( Ball et al , 2016 ), or in vitro OECD test methods that require minimal data generation (eg, genotoxicity, skin, and eye irritation) ( OECD, 2017 , 2018a , b , 2019a , b ).…”